IP Library › Assignment 033163/0133
Patent Assignment
Reel/Frame 033163/0133

Assignment of Assignor's Interest

Recorded: 2014-06-11 Pages: 5
Assignor
THERAVANCE, INC.
Executed: 2014-06-01
Assignee
THERAVANCE BIOPHARMA R&D IP, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080
Covered Properties (4)
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,629,336 →
Application: 11/371,512 →
Publication: US 2006/0205775
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,868,175 →
Application: 12/582,865 →
Publication: US 2010/0041701
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,501,776 →
Application: 12/956,143 →
Publication: US 2011/0071190
Biphenyl compounds useful as muscarinic receptor antagonists
Application: 60/660,475 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 10, 2005
From: JI, YU-HUA; HUSFELD, CRAIG; LI, LI; MAMMEN, MATHAI
To: THERAVANCE, INC.
Reel/Frame 016209/0564 →
Assignment of Assignor's Interest Mar 9, 2006
From: JI, YU-HUA; HUSFELD, CRAIG; LI, LI; MAMMEN, MATHAI
To: THERAVANCE, INC.
Reel/Frame 017667/0819 →
Security Interest Sep 24, 2026
From: THERAVANCE BIOPHARMA R&D IP, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 076134/0790 →